MedPath

Comparision between Vamana Karma and Virechana Karma in Shwitra or Vitiligo.

Phase 3
Completed
Conditions
Health Condition 1: L80- Vitiligo
Registration Number
CTRI/2020/03/023750
Lead Sponsor
IPGT and RA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
22
Inclusion Criteria

1.Patients having sign and symptoms of Shwitra (Vitiligo).

2.Patients indicated for Vamana and Virechana Karma as per Ayurvedic classics.

3.If the patients to withdrawn ongoing medications like systemic corticosteroids, systemic or local photosensitizers or drugs scientifically proven to cause hyperpigmentation on local application or systemic administration will be included. Washout period after quitting will be for 7 days.

4.Patient having chronicity less than or equal to 5 years .

Exclusion Criteria

1.Patients having chronic condition, more than 5 years

2.Patients contraindicated for Vamana & Virechana Karma as per Ayurvedic Classics.

3.Patients having all other de-pigmentory disorders.

4.Patients having serious cardiac, renal, hepatic diseases.

5.Patients having major illness like Hypertension, Diabetes Type 1 & Type 2 which are poorly controlled and any other systemic diseases.

6.Patches due to burning, chemical explosion etc.

7.Located at region of Guhya (Genital region), Panitala (Foot soles and Hand soles), Oshtha (Lips), Sarvanga(whole body).

8.Patches with Raktaroma & Sansakta.

9.Patients with known drug hypersensitivity and photosensitivity.

10.Pregnant and lactating women.

11.Patient having age less than 18 and more than 60.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relief in Sign and Symptoms of ShwitraTimepoint: Relief in Sign and Symptoms of Shwitra within 1 month of trial
Secondary Outcome Measures
NameTimeMethod
Improvement in Quality of Life and Social Wellbeing of patientTimepoint: Improvement in Quality of Life and Social Wellbeing of patient within 1 year of trial
© Copyright 2025. All Rights Reserved by MedPath